These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24970355)

  • 1. Altered expression of ETV1 and its contribution to tumorigenic phenotypes in gastrointestinal stromal tumors.
    Zhang Y; Gu ML; Zhou XX; Ma H; Yao HP; Ji F
    Oncol Rep; 2014 Sep; 32(3):927-34. PubMed ID: 24970355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ETV1 mRNA is specifically expressed in gastrointestinal stromal tumors.
    Jang BG; Lee HE; Kim WH
    Virchows Arch; 2015 Oct; 467(4):393-403. PubMed ID: 26243012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation.
    Kim WK; Park M; Kim YK; Tae YK; Yang HK; Lee JM; Kim H
    Clin Cancer Res; 2011 Dec; 17(24):7584-94. PubMed ID: 22042971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours.
    Chi P; Chen Y; Zhang L; Guo X; Wongvipat J; Shamu T; Fletcher JA; Dewell S; Maki RG; Zheng D; Antonescu CR; Allis CD; Sawyers CL
    Nature; 2010 Oct; 467(7317):849-53. PubMed ID: 20927104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low ETV1 mRNA expression is associated with recurrence in gastrointestinal stromal tumors.
    Sakamaki K; Funasaka K; Miyahara R; Furukawa K; Yamamura T; Ohno E; Nakamura M; Kawashima H; Hirooka Y; Fujishiro M; Goto H
    Sci Rep; 2020 Sep; 10(1):14767. PubMed ID: 32901065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of CIC does not associate with overexpression of ETV1 or MAP kinase pathway activation in gastrointestinal stromal tumors.
    Schoppmann SF; Ricken G; Ilhan-Mutlu A; Nirtl N; Streubel B; Preusser M; Birner P
    Cancer Invest; 2014 Aug; 32(7):363-7. PubMed ID: 24897389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of the RNA-binding protein RBPMS2 in gastrointestinal stromal tumors.
    Hapkova I; Skarda J; Rouleau C; Thys A; Notarnicola C; Janikova M; Bernex F; Rypka M; Vanderwinden JM; Faure S; Vesely J; de Santa Barbara P
    Exp Mol Pathol; 2013 Apr; 94(2):314-21. PubMed ID: 23295309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAPKAP kinase 2 overexpression influences prognosis in gastrointestinal stromal tumors and associates with copy number variations on chromosome 1 and expression of p38 MAP kinase and ETV1.
    Birner P; Beer A; Vinatzer U; Stary S; Höftberger R; Nirtl N; Wrba F; Streubel B; Schoppmann SF
    Clin Cancer Res; 2012 Apr; 18(7):1879-87. PubMed ID: 22351694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined inhibition of MAP kinase and KIT signaling synergistically destabilizes ETV1 and suppresses GIST tumor growth.
    Ran L; Sirota I; Cao Z; Murphy D; Chen Y; Shukla S; Xie Y; Kaufmann MC; Gao D; Zhu S; Rossi F; Wongvipat J; Taguchi T; Tap WD; Mellinghoff IK; Besmer P; Antonescu CR; Chen Y; Chi P
    Cancer Discov; 2015 Mar; 5(3):304-15. PubMed ID: 25572173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin L is highly expressed in gastrointestinal stromal tumors.
    Miyamoto K; Iwadate M; Yanagisawa Y; Ito E; Imai J; Yamamoto M; Sawada N; Saito M; Suzuki S; Nakamura I; Ohki S; Saze Z; Kogure M; Gotoh M; Omicronbara K; Ohira H; Tasaki K; Abe M; Goshima N; Watanabe S; Waguri S; Takenoshita S
    Int J Oncol; 2011 Nov; 39(5):1109-15. PubMed ID: 21769426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survivin is a novel transcription regulator of KIT and is downregulated by miRNA-494 in gastrointestinal stromal tumors.
    Yun S; Kim WK; Kwon Y; Jang M; Bauer S; Kim H
    Int J Cancer; 2018 May; 142(10):2080-2093. PubMed ID: 29277888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic site.
    Antonescu CR; Viale A; Sarran L; Tschernyavsky SJ; Gonen M; Segal NH; Maki RG; Socci ND; DeMatteo RP; Besmer P
    Clin Cancer Res; 2004 May; 10(10):3282-90. PubMed ID: 15161681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of phenothiazine as an ETV1‑targeting agent in gastrointestinal stromal tumors using the Connectivity Map.
    Yen CC; Chen LT; Li CF; Chen SC; Chua WY; Lin YC; Yen CH; Chen YC; Yang MH; Chao Y; Fletcher JA
    Int J Oncol; 2019 Aug; 55(2):536-546. PubMed ID: 31268158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIT Exon 11 Codons 557-558 Deletion Mutation Promotes Liver Metastasis Through the CXCL12/CXCR4 Axis in Gastrointestinal Stromal Tumors.
    Wang HC; Li TY; Chao YJ; Hou YC; Hsueh YS; Hsu KH; Shan YS
    Clin Cancer Res; 2016 Jul; 22(14):3477-87. PubMed ID: 26936919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting ETV1 in gastrointestinal stromal tumors: tripping the circuit breaker in GIST?
    Duensing A
    Cancer Discov; 2015 Mar; 5(3):231-3. PubMed ID: 25749973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTs.
    Martinho O; Gouveia A; Viana-Pereira M; Silva P; Pimenta A; Reis RM; Lopes JM
    Histopathology; 2009 Jul; 55(1):53-62. PubMed ID: 19614767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumours.
    Gits CM; van Kuijk PF; Jonkers MB; Boersma AW; van Ijcken WF; Wozniak A; Sciot R; Rutkowski P; Schöffski P; Taguchi T; Mathijssen RH; Verweij J; Sleijfer S; Debiec-Rychter M; Wiemer EA
    Br J Cancer; 2013 Sep; 109(6):1625-35. PubMed ID: 23969726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and gene mutation of phospho-platelet derived growth factor receptor alpha and C-kit in gastrointestinal and extra-gastrointestinal stromal tumors].
    Tang M; Li DQ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jan; 11(1):80-3. PubMed ID: 18197502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The GIST paradigm: how to establish diagnostic and prognostic criteria.
    Calabuig-Farinas S; Lopez-Guerrero JA; Llombart-Bosch A
    Arkh Patol; 2011; 73(4):13-21. PubMed ID: 22164425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
    Miettinen M; Sobin LH; Lasota J
    Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.